Chronic heart failure: a reversible metabolic syndrome?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

22 citing papers in PubMed.

1. Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms.Circulation research · 2026
   Review
2. Sex-Specific Associations Between Anthropometric Indices and Left Ventricular Hypertrophy in Middle-Aged and Elderly Individuals with Type 2 Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
   Article
3. Mitochondrial Dysfunction in Cardiac Disease: The Fort Fell.Biomolecules · 2024
   Review
4. Heart Failure: A Deficiency of Energy-A Path Yet to Discover and Walk.Biomedicines · 2024
   Review
5. Metabolic Consequences of Advanced Chronic Heart Failure and its Modification by Implantation of a Durable Left Ventricular Assist Device.Reviews in cardiovascular medicine · 2024
   Review
6. Metabolic Adaptation in Heart Failure and the Role of Ketone Bodies as Biomarkers.Current heart failure reports · 2024
   Review
7. Gene expression and ultra-structural evidence for metabolic derangement in the primary mitral regurgitation heart.European heart journal open · 2024
   Article
8. Cardiac lipid metabolism, mitochondrial function, and heart failure.Cardiovascular research · 2023
   Review
9. Chronic ablation of TRPV1-sensitive skeletal muscle afferents attenuates the muscle metaboreflex.American journal of physiology. Regulatory, integrative and comparative physiology · 2021
   Article
10. Prognostic value of leucine/phenylalanine ratio as an amino acid profile of heart failure.Heart and vessels · 2021
    Observational
11. A quantitative detection of Cardiotrophin-1 in chronic heart failure by chemiluminescence immunoassay.Journal of clinical laboratory analysis · 2021
    Article
12. Association between admission plasma 2-oxoglutarate levels and short-term outcomes in patients with acute heart failure: a prospective cohort study.Molecular medicine (Cambridge, Mass.) · 2019
    Article
13. Skeletal Muscle Resident Progenitor Cells Coexpress Mesenchymal and Myogenic Markers and Are Not Affected by Chronic Heart Failure-Induced Dysregulations.Stem cells international · 2019
    Article
14. 2017 George Lyman Duff Memorial Lecture: Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.Arteriosclerosis, thrombosis, and vascular biology · 2018
    Review
15. Nutrients restriction upregulates adiponectin in epicardial or subcutaneous adipose tissue: impact inInternational journal of medical sciences · 2018
    Article
16. Metabolic Reprogramming After Left Ventricular Assist Device: Remodeling Without Recovery of Cardiac Energetics.JACC. Basic to translational science · 2016
    Article
17. KLF15 and PPARα Cooperate to Regulate Cardiomyocyte Lipid Gene Expression and Oxidation.PPAR research · 2015
    Article
18. Serum Angiopoietin-Like Protein 2 Concentrations Are Independently Associated with Heart Failure.PloS one · 2015
    Article
19. Relation of regional fat distribution to left ventricular structure and function.Circulation. Cardiovascular imaging · 2013 · on this map
    Article
20. Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure.Heart failure reviews · 2013
    Review

Corrections and comments

• Comment on
  Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure.2012

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as